Copper Complexes with Indomethacin: Anti-Inflammatory Properties
Author Information
Author(s): Fadila Guessous, Jean-Claude Daran, Bernard Viossat, Georges Morgant, Xavier Labouze, Anne Laure Leroy, Monique Roch-Arveiller, Nguyen-Huy Dung
Primary Institution: CNRS URA 1534, Laboratoire de Pharmacologie, Hôpital Cochin, Paris, France
Hypothesis
Can copper(II) complexes of indomethacin reduce gastrointestinal side effects while maintaining anti-inflammatory efficacy?
Conclusion
The copper(II) complex of indomethacin showed reduced gastrointestinal inflammation compared to indomethacin alone.
Supporting Evidence
- Daily administration of the copper complex did not induce gastric or intestinal damages.
- Encapsulation of the copper complex reduced inflammation markers compared to indomethacin alone.
- Significant enhancement of myeloperoxidase activity was observed with indomethacin treatment.
Takeaway
This study found that a special copper medicine can help reduce stomach problems caused by another medicine while still helping with inflammation.
Methodology
Rats were treated with either indomethacin or the copper complex, and various inflammatory markers were measured in intestinal tissues.
Potential Biases
Potential bias in the selection of treatment dosages and the method of measuring inflammation.
Limitations
The study was conducted on a small sample size of rats, which may limit the generalizability of the results.
Participant Demographics
Male Sprague-Dawley rats, weighing 160 to 180 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website